Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

[Angiopeptin versus placebo for reductin of restenosis after PTCA treatment. A randomized, double-blind study].

[Angiopeptin versus placebo for reductin of restenosis after PTCA treatment. A randomized, double-blind study]. Ugeskr Laeger. 1996 Nov 11; 158(46):6605-8.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.